Home › Trial NCT00431054
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
- Trial IDNCT00431054
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment22
- Start date2007-02
- ConditionsOvarian Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.